| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Self Improvement > Addictions > Successful Addiction Treatments |
|
Advice Pool - Successful Addiction Treatments
There has been an enormous increase in the number of people seeking treatment for stimulant addictions over the p According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ast few years. The majority of individuals seeking treatment are likely to be poly-drug users, or users of many s ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in bstances. So, such addiction is a complex problem with a myriad of biological, social, familial, and environmenta lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. l factors. Therefore, the treatment is usually complex and must address a variety of problems involving the psych here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe biological, social, and pharmacological aspects of the patients' drug abuse. With the treatment process being co d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro mplex, organizations are aggressively pursuing the identification and testing of new treatment medications. Sever ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc l newly emerging compounds are being investigated to assess their safety and efficacy in treating addiction. One easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi of the most promising drug medications to date is Selegeline. Disulfiram, a medication that has been used to trea nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically alcoholism, has also been shown in clinical studies to be effective in reducing drug abuse. Because of mood chan and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ges experienced during the early stages of drug abstinence, antidepressant drugs produce great benefits. Many be ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi avioral treatments have been found to be very effective including both residential and outpatient approaches. Int ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a egration of both types of treatments is proved to be the most effective approach for treating addiction. This may dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod include adding to or removing from an individual's treatment regimen different components or elements. A famous cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin behavioral therapy component that shows positive results in many drug-addicted populations is contingency managem tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nt. Contingency management uses a voucher-based system to give positive rewards for staying in treatment and rema t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ining drug free. Based on drug-free urine tests, the patients earn points that can be exchanged for items capable ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust of encouraging healthy living, such as joining a gym or going to a movie and dinner. Cognitive-behavioral therap y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products y is another approach to help them abstain from drugs. It emphasizes addicts during the learning process about th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de addicting conditions and guides them to refrain from them in the future. Therapeutic communities or residential elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip programs with planned lengths of stay of 6 to 12 months focus on the resocialization of the individual to society tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Online Schools - Why Online Courses? Women's Fitness Training Tips: Great Arms and Legs In Ten Minutes A Day
|